(Q43855425)

27 November 2017

title

Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridol (English)

1 reference

27 November 2017

Igor Semenov

1

1 reference

27 November 2017

Canan Akyuz

2

1 reference

27 November 2017

Vera Roginskaya

3

1 reference

27 November 2017

Dharminder Chauhan

4

1 reference

27 November 2017

Seth J Corey

5

1 reference

27 November 2017

publication date

1 March 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

26

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

271-280

1 reference

The treatment of multiple myeloma

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

Ten-year survival and prognostic factors in multiple myeloma. Japan Myeloma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

Thalidomide--a revival story

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

Preclinical and clinical development of cyclin-dependent kinase modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

Isolation and characterization of human multiple myeloma cell enriched populations

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900103-5

7 January 2021

10.1016/S0145-2126(01)00103-5

Identifiers

DOI

1 reference

27 November 2017

1 reference